4368 — Fuso Chemical Co Balance Sheet
0.000.00%
- ¥169bn
- ¥161bn
- ¥70bn
- 94
- 52
- 98
- 96
Annual balance sheet for Fuso Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 25,707 | 24,360 | 23,413 | 31,472 | 31,296 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 10,537 | 14,873 | 14,954 | 16,445 | 16,031 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 45,131 | 52,078 | 55,344 | 68,134 | 67,052 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 25,924 | 35,291 | 54,302 | 59,027 | 66,983 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 76,032 | 92,010 | 113,529 | 133,740 | 141,502 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7,836 | 14,667 | 23,909 | 16,457 | 18,490 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 9,863 | 16,706 | 26,026 | 38,715 | 37,453 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 66,170 | 75,303 | 87,503 | 95,025 | 104,049 |
| Total Liabilities & Shareholders' Equity | 76,032 | 92,010 | 113,529 | 133,740 | 141,502 |
| Total Common Shares Outstanding |